Strategic partnership Resonate with opportunities from Resonetics integration news to position MED-ALLY as a complementary partner for energy source and active implantable device manufacturing, targeting neuromodulation, BCI, and CRM markets.

Growth potential Leverage past headcount expansion and new Goose Creek facility investments to underscoring capacity to scale for larger production runs and multi-channel VersaStim platform deployments.

Compact scale Target mid-market medical device buyers who require high complexity, configurable implantable systems with multi-channel capabilities, aligning with VersaStim’s modular, rapid customization to reduce time-to-market.

Financial signal Revenue range indicates a smaller but growing operation; position MED-ALLY for scalable engagements with mid-size hospitals, clinics, and contract manufacturers seeking specialized implantable solutions.

Market fit Emphasize neuromodulation, bioelectronic, and BCI advancement as core growth vectors, pursuing customers in neuromodulation clinics, research centers, and allied CRM domains needing robust, field-ready implantable platforms.